ArticleMicrosystems & nanoengineering2026
Coupling inertial, viscoelastic, and enhanced secondary flow in a composite microchannel: achieving high-precision multi-sized particle 3D central co-focusing.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Microfluidic particle focusing is essential for diverse biomedical applications. However, conventional inertial focusing techniques are limited by particle size dependency, hindering effective 3D central co-focusing of particles with varying sizes. In this study, we introduced a novel microfluidic method based on an inertial-viscoelastic-secondary flow synergistic effect (INVEST) within a composite microchannel (CMC), enabling high-efficiency 3D co-focusing of multi-sized particles. The CMCs incorporated height-varying horizontal and vertical semicircular obstacles to modulate inertial and secondary flows, while hyaluronic acid (HA) was introduced to enhance the viscoelastic effect and balance the force disparities among particles. Comprehensive numerical simulations were conducted to analyze the main flow field, secondary flow vectors, and shear-rate distributions. A novel metric, equilibrium zone width (EZW), was first proposed to theoretically assess the focusing performance. The simulation results indicated a minimal EZW of 15.58 μm. Moreover, experimental validations across various HA concentrations, obstacle configurations, and particle sizes demonstrated focusing widths below 20.5 μm and efficiencies exceeding 95% for particle mixtures with diameters from 10 to 20 μm. Further testing using white blood cells confirmed a focusing efficiency of 96.14%. These findings verified that the CMCs successfully integrated inertial migration, viscoelastic effects, and enhanced secondary flows to realize the INVEST mechanism within a single microchannel, effectively addressing the issues of size dependency of traditional inertial focusing and the corner attraction effect of viscoelastic focusing. The developed microfluidic platform enables robust 3D central co-focusing of multi-sized particles and heterogeneous cells, providing a promising solution for high-throughput microflow cytometry and single-cell analysis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.